You're reading the free version. Trader adds the live tape and alerts.
Start tracking
REGN Sale Disclosure
Pitofsky Jason · SEC Form 4 · Filed Nov 6, 2026
Sale
Calculated transaction value
$499.13K
Pitofsky Jason SVP Controller
REGN
Transaction date
Nov 4, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 2 days later
REGN daily price context
Close on/before transaction
$930.67
Nov 4, 2026
First close after public filing
$919.96
Nov 9, 2026
Return after filing · so far
+4.29%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 529 shares @ $943.53
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002009236-26-000003
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.31M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN Current | Sale | Nov 4, 2026 | $499.13K |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 4, 2026 | $0 |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 4, 2026 | $170.19K |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 4, 2026 | $0 |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 4, 2026 | $0 |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 4, 2026 | $412.47K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 4, 2026 | $540.76K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 4, 2026 | $924.63K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 4, 2026 | $1.14M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 4, 2026 | $101.98K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 4, 2026 | $33.1K |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 4, 2026 | $1.09M |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 4, 2026 | $952.63K |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 4, 2026 | $445.26K |